TNL Mediagene Ordinary Shares (TNMG)vsJohn Wiley & Sons (WLY)
TNMG
TNL Mediagene Ordinary Shares
$2.00
+1.88%
COMMUNICATION SERVICES · Cap: $81.09M
WLY
John Wiley & Sons
$37.39
+1.71%
COMMUNICATION SERVICES · Cap: $1.86B
Smart Verdict
WallStSmart Research — data-driven comparison
John Wiley & Sons generates 3264% more annual revenue ($1.67B vs $49.67M). WLY leads profitability with a 9.2% profit margin vs -1.7%. WLY earns a higher WallStSmart Score of 58/100 (C).
TNMG
Avoid27
out of 100
Grade: F
WLY
Buy58
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for TNMG.
Margin of Safety
+63.7%
Fair Value
$81.22
Current Price
$37.39
$43.83 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Every $100 of equity generates 22 in profit
Attractively priced relative to earnings
Reasonable price relative to book value
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -1.6% — below average capital efficiency
Negative free cash flow — burning cash
1.3% revenue growth
Smaller company, higher risk/reward
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : TNMG
The strongest argument for TNMG centers on Price/Book.
Bull Case : WLY
The strongest argument for WLY centers on Return on Equity, P/E Ratio, Price/Book.
Bear Case : TNMG
The primary concerns for TNMG are EPS Growth, Market Cap, Return on Equity.
Bear Case : WLY
The primary concerns for WLY are Revenue Growth, Market Cap, PEG Ratio.
Key Dynamics to Monitor
TNMG profiles as a turnaround stock while WLY is a value play — different risk/reward profiles.
TNMG carries more volatility with a beta of 1.24 — expect wider price swings.
TNMG is growing revenue faster at 5.7% — sustainability is the question.
WLY generates stronger free cash flow (167M), providing more financial flexibility.
Bottom Line
WLY scores higher overall (58/100 vs 27/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
TNL Mediagene Ordinary Shares
COMMUNICATION SERVICES · PUBLISHING · USA
TNL Mediagene Ordinary Shares is a cutting-edge biopharmaceutical company dedicated to developing and commercializing innovative medical therapies aimed at addressing significant unmet health needs, with a focus on oncology and autoimmune disorders. By employing advanced technologies and fostering strong strategic partnerships, the company is strategically positioned for robust growth and long-term value creation. TNL Mediagene’s unwavering commitment to scientific innovation and research-driven approaches highlights its mission to improve patient outcomes and broaden the therapeutic landscape within the biopharmaceutical sector.
Visit Website →John Wiley & Sons
COMMUNICATION SERVICES · PUBLISHING · USA
John Wiley & Sons, Inc. (WLY) is a leading global provider of educational materials and research solutions, dedicated to advancing knowledge across diverse sectors. With a robust portfolio that includes academic publishing, professional development resources, and innovative digital platforms, Wiley effectively supports learners and professionals alike in an ever-evolving educational landscape. The company's strategic emphasis on digital transformation and content accessibility positions it as a trusted partner in enhancing educational and research productivity, ensuring its relevance and leadership in the industry. Through its commitment to quality and innovation, Wiley remains well-equipped to address the evolving needs of its global clientele.
Compare with Other PUBLISHING Stocks
Want to dig deeper into these stocks?